Sort
21,453 grants matching “tuberculosis”
INDIANA STATE DEPT OF HEALTH TUBERCULOSIS ELIMINATION AND LABORATORY COOPERATIVE
$686,559Sarah Burkholder · Indiana State Department Of Health · U52 · FY2013 · PS
IL-2/Treg-based immunity to TB and AIDS-related TB
$686,553Zheng W Chen · University Of Illinois At Chicago · R01 · FY2011 · HL
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics
$686,519Michael R Wilson · University Of California, San Francisco · R01 · FY2020 · AI
The Warburg effect and host immune response in tuberculosis
$686,411Lanbo Shi · Rbhs-New Jersey Medical School · R01 · FY2019 · AI
Long Acting Injectable Depots for TB Therapy
$686,389Patrick S. Stayton · University Of Washington · R61 · FY2021 · AI
Development and Testing of New Tuberculosis Vaccines
$686,321Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2006 · AI
Fox COBRE Phase II Admin Core
$686,141Joseph M Fox · University Of Delaware · P20 · FY2020 · GM
URBAN ARCH (3/5) Uganda Cohort TB preventive therapy for HIV-infected alcohol users in Uganda: an evaluation of safety tolerability and adherence
$686,017Judith Alissa Hahn · University Of California, San Francisco · U01 · FY2016 · AA
Human-centered Design and Communities of Practice to Improve Delivery of Home-based TB Contact Investigation in Uganda
$685,913John Lucian Davis · Yale University · R01 · FY2022 · AI
IgM in the regulation of TB immunity
$685,810John R. Chan · Albert Einstein College Of Medicine · R01 · FY2021 · AI
Development and Testing of New Tuberculosis Vaccines
$685,682Marcus Aaron Horwitz · University Of California Los Angeles · R01 · FY2007 · AI
The regulation and functions of Group 1 CD1-restricted T cells
$685,629Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2025 · AI
The regulation and functions of Group 1 CD1-restricted T cells
$685,629Chyung-Ru Wang · Northwestern University At Chicago · R01 · FY2024 · AI
Epidemiology of Helicobacter Pylori Transmission
$685,412Julie Parsonnet · Stanford University · R01 · FY2006 · AI
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$685,339Evan Alexander Scott · Northwestern University · R01 · FY2019 · AI
Design and characterization of biomimetic nanobiomaterials to elicit CD1-restricted T cell responses during sub-unit vaccination
$685,339Evan Alexander Scott · Northwestern University · R01 · FY2020 · AI
The Warburg effect and host immune response in tuberculosis
$685,290Lanbo Shi · Rbhs-New Jersey Medical School · R01 · FY2018 · AI
The Warburg effect and host immune response in tuberculosis
$685,290Lanbo Shi · Rbhs-New Jersey Medical School · R01 · FY2017 · AI
Strengthening evidence on optimal multidrug-resistant tuberculosis treatment regimens through improved epidemiologic methods
$685,092Molly Forrest Franke · Harvard Medical School · R01 · FY2022 · AI
Early and accurate diagnosis of pulmonary and extrapulmonary tuberculosis in all patient groups using a circulating pathogen-derived antigen
$685,056Thomas W Tombler · Nanopin Technologies, Inc. · R44 · FY2023 · AI
PET Probes Targeting Immune Cells for Imaging Tuberculosis
$685,055Carolyn J Anderson · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI
Development Of A Vaccine For Leishmania Major Infection
$685,037Robert A Seder · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Simplified Isoniazid Preventive Therapy (SPIRIT) Strategy to Reduce TB Burden
$684,762Diane V Havlir · University Of California, San Francisco · R01 · FY2020 · AI
Regulation Of Immunopathology In Bacterial And Parasitic Disease
$684,754Alan Sher · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Mapping and modeling host-pathogen interactions in TB latency and reactivation
$684,605Maria Laura Gennaro · Rbhs-New Jersey Medical School · R01 · FY2013 · HL